Advanced Colorectal Cancer Is Associated With Enhanced IL-23 and IL-10 Serum Levels (original) (raw)

The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival

Charles Evans

British Journal of Cancer, 2006

View PDFchevron_right

The interleukin-23 axis in intestinal inflammation

Ana Izcue

Immunological Reviews, 2008

View PDFchevron_right

The Effect of the COVID-19 Pandemic on the Clinical and Pathological Stages of Colorectal Cancer Patients

Mehmet Özçelik

Turkish Journal of Colorectal Disease

View PDFchevron_right

Interleukin-24 is correlated with differentiation and lymph node numbers in rectal cancer

choi youngmin

World Journal of Gastroenterology, 2011

View PDFchevron_right

Interleukin 23 in Crohnʼs Disease

ahmet eken

Inflammatory Bowel Diseases, 2014

View PDFchevron_right

Colorectal cancer screening in the COVID-19 era

Roque Saenz

World Journal of Gastrointestinal Oncology, 2021

View PDFchevron_right

Colorectal cancer-associated nuclear antigen

Wanda Krajewska

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000

View PDFchevron_right

Body Mass Index and Colon Cancer Mortality in a Large Prospective Study

Carmen Rodriguez

View PDFchevron_right

Contributing factors common to COVID‑19 and gastrointestinal cancer

Nikolaos Drakoulis

Oncology Reports, 2021

View PDFchevron_right

Colorectal cancer: influence of diet and lifestyle factors

Angelos K Sikalidis

Revista Española de Enfermedades Digestivas, 2005

View PDFchevron_right

Inflammation, atrophy, and gastric cancer

James Fox

Journal of Clinical Investigation, 2007

View PDFchevron_right

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer

N. Mortensen

British Journal of Cancer

View PDFchevron_right

Expression of CD44s in human colorectal cancer

Mousa Khoursheed

Pathology & Oncology …, 2002

View PDFchevron_right

Potentially curable metastatic colorectal cancer

Matthew Katz

Current Oncology Reports, 2008

View PDFchevron_right

Randomized Clinical Trials in Colon and Rectal Cancer

Atif Iqbal

Surgical Oncology Clinics of North America, 2017

View PDFchevron_right

Enterohormonal disturbances in colorectal cancer patients

Jolanta Kaszuba-Zwoińska

Neoplasma, 2017

View PDFchevron_right

Immune system: a double-edged sword in cancer

Lakshmi Narendra

Inflammation Research, 2013

View PDFchevron_right

Should we screen for colorectal cancer?

Angela plunkett

New South Wales Public Health Bulletin, 1994

View PDFchevron_right

Increased Cumulative Incidence of Prostate Malignancies in Colorectal Cancer Patients

Nuri Ozden

International Journal of Gastrointestinal Cancer, 2004

View PDFchevron_right

Young age is not a poor prognostic marker in colorectal cancer

Nyam Nyam Nyam

British Journal of Surgery, 1998

View PDFchevron_right

Association of Inflammatory Markers with Colorectal Cancer Incidence in the Atherosclerosis Risk in Communities Study

Anna Prizment

Cancer Epidemiology Biomarkers & Prevention, 2011

View PDFchevron_right

This is a call to oncologists for action

Miriam Lobo

Clinical & Translational Oncology, 2018

View PDFchevron_right

A pilot study on risk factors and p53 gene expression in colorectal cancer

Peter Söderkvist

British Journal of Cancer, 1996

View PDFchevron_right

Metabolic pathways regulating colorectal cancer initiation and progression

Carlos Sebastián

Seminars in Cell & Developmental Biology

View PDFchevron_right

A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Alamgir khan

Clinical Proteomics, 2015

View PDFchevron_right